THE BAY MEDICAL PRACTICE
BROADWAY, SANDOWNHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 42 | 56 | 75.0% | |
HF 4 | 2011 | 42 | 62 | 67.7% | |
HF 4 | 2012 | 40 | 53 | 75.5% | |
HF 4 | 2013 | 44 | 59 | 74.6% | |
HF004 | 2014 | 72 | 81 | 88.9% | |
HF004 | 2015 | 67 | 76 | 88.2% | |
HF004 | 2016 | 77 | 89 | 86.5% | |
HF004 | 2017 | 70 | 79 | 88.6% | |
HF004 | 2018 | 63 | 68 | 92.6% | |
HF004 | 2019 | 64 | 69 | 92.8% | |
HF004 | 2020 | 64 | 70 | 91.4% | |
HF006 | 2021 | 252 | 292 | 86.3% | |
HF006 | 2022 | 258 | 280 | 92.1% | |
HF006 | 2023 | 269 | 296 | 90.9% |